Skip to main content
Help
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Private Companies
Technical Chart
Fundamental Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Tools
Collapse
Alebund Pharmaceuticals (Jiangsu) Limited (HKG:9637)
Hong Kong
· Delayed Price · Currency is HKD
Full Chart
Watchlist
Alerts
Compare
28.92
-1.04 (-3.47%)
Last updated: Jul 16, 2026, 11:59 AM HKT
Overview
Financials
Statistics
History
Profile
Chart
Income Statement
Balance Sheet
Cash Flow
Ratios
Annual
Quarterly
TTM
HKG:9637 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Mil
Millions
Data
Data Source
CNY
CNY
More
Download
Full Width
Fiscal Year
FY 2025
FY 2024
Period Ending
Dec '25
Dec 31, 2025
Dec '24
Dec 31, 2024
Cash & Equivalents
358.33
343.77
Short-Term Investments
28.22
22.4
Trading Asset Securities
145.46
-
Cash & Short-Term Investments
532
366.17
Cash Growth
45.29%
-
Accounts Receivable
-
0.87
Other Receivables
0.68
7.4
Receivables
0.68
14.12
Inventory
10.27
6.12
Other Current Assets
15.77
2.37
Total Current Assets
558.72
388.78
Property, Plant & Equipment
612.94
628.04
Long-Term Investments
66.64
3.26
Other Intangible Assets
9.04
10.39
Other Long-Term Assets
92.6
78.68
Total Assets
1,340
1,109
Accounts Payable
67.77
25.88
Accrued Expenses
21.32
18.43
Current Portion of Long-Term Debt
-
28
Current Portion of Leases
3.69
3.69
Current Unearned Revenue
67.2
-
Other Current Liabilities
79.85
1,868
Total Current Liabilities
239.83
1,944
Long-Term Debt
545.33
445.3
Long-Term Leases
0.4
2.16
Long-Term Unearned Revenue
49.2
40.31
Other Long-Term Liabilities
1.94
18.6
Total Liabilities
836.69
2,450
Common Stock
283.1
153.62
Retained Earnings
-1,365
-1,165
Comprehensive Income & Other
1,585
-319.04
Total Common Equity
503.24
-1,330
Minority Interest
-
-10.81
Shareholders' Equity
503.24
-1,341
Total Liabilities & Equity
1,340
1,109
Total Debt
549.42
479.15
Net Cash (Debt)
-17.42
-112.98
Net Cash Per Share
-0.07
-0.42
Filing Date Shares Outstanding
283.1
271.6
Total Common Shares Outstanding
283.1
271.6
Working Capital
318.89
-1,555
Book Value Per Share
1.78
-4.90
Tangible Book Value
494.2
-1,341
Tangible Book Value Per Share
1.75
-4.94
Buildings
392.08
377.69
Machinery
239.81
230.31
Construction In Progress
2.32
1.24
Leasehold Improvements
16.15
15.8